To achieve and maintain the highest level of EU pandemic readiness through the establishment
of a consortium enabling research and development of safe
and effective vaccines and monoclonal antibodies.
Stay informed about key developments, scientific breakthroughs, partnerships, and policy updates related to pandemic vaccine preparedness across Europe.
Extended Application deadline: 5 July 2026 The European Vaccines Hub (EVH) is launching a call for internationally recognized experts to join its independent External Advisory Committee (iEAC). This [...]
In March 2026, in Brussels, the European Vaccines Hub (EVH) met with the Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI) to explore opportunities for collaboration in vaccine resea [...]
The European Vaccines Hub (EVH), mandated by HERA, is inviting manufacturers - CMOs, CDMOs, biopharma companies - to share information on GMP vaccine and monoclonal antibody manufacturing capabilities [...]
European Vaccines Hub (EVH) invites prospective collaborators to contribute to the advancement of promising pandemic influenza vaccine candidates, with the overarching objective of strengthening pan [...]
Discover EVH - its mission, structure, and strategic goals to strengthen pandemic preparedness through innovation and scientific excellence.
The European Vaccine Hub (EVH) unites leading experts, institutions, and innovators to boost pandemic vaccine preparedness across Europe through collaboration, research, and shared solutions.
EU4H-2024-PJ-01-1
€169.992.330
(EC contribution: €101.995.398)
4 years
(1st March 2025-28th February 2029)
Sclavo Vaccines Association (IT)
Join relevant upcoming conferences, workshops and key gatherings across Europe.
The European Vaccines Hub (EVH) for Pandemic Readiness, convenes its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from 19 to 21 May 2026. Just one ye...
Organized by the University of Marburg, a hybrid seminar addressing key questions at the interface of pandemic preparedness and vaccine innovation will be held on 19 May 2026. More information: Down...
As part of the Virology Seminar Series organized by the University of Marburg, a hybrid seminar highlighting breakthroughs in vaccine development for BSL-4 pathogens will be held on 23 March 2026. ...
© Copyright 2025 The European Vaccine Hub. All rights reserved
Designed and Developed by Pixwork